Digital Health
Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.
From 2000 to 2017, the number of registered clinical trials featuring CGMs, apps and other connected devices rose at a 34% CAGR, according to new data from Harvard researchers.
Also: FDA clears Nuvo Group's fetal and maternal heart monitor for pregnant women; Innovaccer, Sanitas USA launch virtual COVID-19 care app.
The PPG-based feature automatically measures the wearer's heart rhythm every five minutes, and will be ready for integration with a range of devices later this year.
The proposal would fully fund telehealth services and devices for eligible healthcare providers, although some aren't pleased with its exclusion of for-profit hospitals.
COVID-19
German-based Ralf Jahns, MD at Research2Guidance, explains the role of different stakeholders in fighting COVID-19.
Both efforts are employing popular consumer wearables and health trackers to spot potential cases of COVID-19 or other viral diseases as they begin.
Digital health investors discuss the opportunity, responsibility and liability of investing in health tech during market volatility and a possible recession.
Online mental health support is increasingly important as communities face lockdown and social distancing measures.
Also: Welltok expands to Latin America with insurer partnership; Kyruus and GYANT combine their offerings for health system clients.